當(dāng)前位置：首頁 JCRQ2 期刊介紹(非官網(wǎng))

PituitarySCIE

國際簡稱：PITUITARY 參考譯名：垂體

中科院分區(qū)
2區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q2

基本信息：: ISSN：1386-341X; E-ISSN：1573-7403; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：是

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Springer US; 出版語言：English; 出版周期：Quarterly; 出版年份：1998; 研究方向：醫(yī)學(xué)-內(nèi)分泌學(xué)與代謝

評(píng)價(jià)信息：: 影響因子：3.3; H-index：57; CiteScore指數(shù)：7.1; SJR指數(shù)：1.091; SNIP指數(shù)：1.209

發(fā)文數(shù)據(jù)：: Gold OA文章占比：31.73%; 研究類文章占比：79.17%; 年發(fā)文量：72; 自引率：0.0789...; 開源占比：0.2943; 出版撤稿占比：0; 出版國人文章占比：0.06; OA被引用占比：0.2315...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Pituitary期刊介紹

Pituitary is an international publication devoted to basic and clinical aspects of the pituitary gland. It is designed to publish original, high quality research in both basic and pituitary function as well as clinical pituitary disease.

The journal considers:

Biology of Pituitary Tumors

Mechanisms of Pituitary Hormone Secretion

Regulation of Pituitary Function

Prospective Clinical Studies of Pituitary Disease

Critical Basic and Clinical Reviews

Pituitary is directed at basic investigators, physiologists, clinical adult and pediatric endocrinologists, neurosurgeons and reproductive endocrinologists interested in the broad field of the pituitary and its disorders. The Editorial Board has been drawn from international experts in basic and clinical endocrinology. The journal offers a rapid turnaround time for review of manuscripts, and the high standard of the journal is maintained by a selective peer-review process which aims to publish only the highest quality manuscripts. Pituitary will foster the publication of creative scholarship as it pertains to the pituitary and will provide a forum for basic scientists and clinicians to publish their high quality pituitary-related work.

期刊簡介Pituitary期刊介紹

《Pituitary》自1998出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：約6月
國際TOP期刊
醫(yī)學(xué)
ENDOCRINOLOGY & METABOLISM
SCIE
中科院2區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Pituitary Cite Score數(shù)據(jù)

CiteScore：7.1
SJR：1.091
SNIP：1.209

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Endocrinology, Diabetes and Metabolism	Q2	66 / 244	73%
大類：Medicine 小類：Endocrinology	Q2	44 / 128	66%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Pituitary 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	2區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學(xué)與代謝	2區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Pituitary JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	77 / 186	58.9%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	64 / 186	65.86%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計(jì)

國家/地區(qū)數(shù)量
USA84
Italy40
GERMANY (FED REP GER)26
CHINA MAINLAND24
England23
Netherlands21
Brazil16
France15
Spain15
Turkey14

本刊中國學(xué)者近年發(fā)表論文

1、A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly
Author: Fleseriu, M.; Zhang, Z.; Hanman, K.; Haria, K.; Houchard, A.; Khawaja, S.; Ribeiro-Oliveira, A., Jr.; Gadelha, M.

Journal: PITUITARY. 2023; Vol. 26, Issue 1, pp. 9-41. DOI: 10.1007/s11102-022-01285-1
2、Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review
Author: Ji, Xiaoyu; Fu, Jiajia; Li, Xiaozhe; Yuan, Kun; Sun, Xuebo; Yao, Qiaoling

Journal: PITUITARY. 2023; Vol. 26, Issue 1, pp. 1-8. DOI: 10.1007/s11102-022-01287-z
3、A procedure in mice to obtain intact pituitary-infundibulum-hypothalamus preparations: a method to evaluate the reconstruction of hypothalamohypophyseal system
Author: Li, Kai; Xiong, Zhiwei; Zhou, Mingfeng; Ou, Yichao; Li, Weizhao; Wu, Guangsen; Che, Mengjie; Gong, Haodong; Wang, Xingqin; Peng, Junjie; Zheng, Xiaoxuan; Li, Jiahui; Feng, Zhanpeng; Peng, Junxiang

Journal: PITUITARY. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11102-023-01299-3
4、AcroVoice: the controversial values in reflecting acromegaly disease activity
Author: Zihao Wang, Bing Xing

Journal: Pituitary, 2019, Vol., , DOI:10.1007/s11102-019-00950-2
5、Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China
Author: Yanyan Wu, Lu Gao, Xiaopeng Guo, Zihao Wang, Wei Lian, Kan Deng, Lin Lu, Bing Xing, Huijuan Zhu

Journal: Pituitary, 2019, Vol., , DOI:10.1007/s11102-019-00939-x
6、A small 3D-printing model of macroadenomas for endoscopic endonasal surgery
Author: Xing Huang, Zhen Liu, Xuan Wang, Xu-dong Li, Kai Cheng, Yan Zhou, Xiao-bing Jiang

Journal: Pituitary, 2018, Vol., , DOI:10.1007/s11102-018-0927-x
7、Transsphenoidal approach for pituitary adenomas in patients with McCune–Albright syndrome
Author: Wanchen Dou, Xiao Di, Renzhi Wang, Huijuan Zhu, Yong Yao, Kan Deng, Ming Feng, Guilin Li, Junji Wei

Journal: Pituitary, 2012, Vol.16, 231-237, DOI:10.1007/s11102-012-0408-6
8、Downregulation of Insulin-like growth factor binding protein 6 is associated with ACTH-secreting pituitary adenoma growth
Author: Yakun Yang, Miaomiao Sheng, Fengming Huang, Dechao Bu, Xiaohai Liu, Yong Yao, Congxin Dai, Bowen Sun, Jindong Zhu, Yonghui Jiao, Zhenqing Wei, Huijuan Zhu, Lin Lu, Yi Zhao, Chengyu Jiang, Renzhi Wang

Journal: Pituitary, 2013, Vol.17, 505-513, DOI:10.1007/s11102-013-0535-8